>아시아 태평양 암 침 검사 장치 시장, 제품 유형별(침 채취 키트, 체액 특정 장치, 구강 면봉, 바코드 라벨, 침 냉동 보관 상자 및 기타), 채취 부위(하악하선/설하선, 이하선 및 소침샘), 적용 분야(간폐암, 유방암, 대장 및 직장암, 전립선암, 췌장암, 구강암, 갑상선암, 자궁내막암, 신장암, 백혈병, 흑색종, 비호지킨 림프종 및 기타), 연령대(성인 및 소아), 채취 방법 (수동 침, 구강 면봉 및 기타), 최종 사용자(병원, 진단 실험실, 종양학 전문 클리닉, 암 연구소 및 기타), 유통 채널(직접 입찰, 소매 판매 및 기타) 국가(중국, 일본, 인도, 한국, 호주, 싱가포르, 태국, 말레이시아, 인도네시아, 필리핀 및 기타 아시아 태평양 지역의 산업 동향 및 2028년 예측.
시장 분석 및 통찰력: 아시아 태평양 암 침 검사 장치 시장
아시아 태평양 암 침 검사 장비 시장은 2021년부터 2028년까지의 예측 기간 동안 상당한 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 아시아 태평양 암 침 검사 장비 시장이 2021년부터 2028년까지의 예측 기간 동안 10.5%의 CAGR로 성장하고 있으며 2020년 9,848만 달러에서 2028년까지 2억 946만 달러에 도달할 것으로 예상된다고 분석했습니다. 만성 질환의 유병률 증가와 암 환자 수 증가가 주요 동인으로, 예측 기간 동안 시장 성장을 촉진할 것으로 예상됩니다.
타액 검사 는 오늘날 암 탐지에 광범위하게 사용됩니다. 암 타액은 돌연변이된 세포외 DNA와 RNA의 존재 또는 부재를 검사합니다. 종양 세포는 순환계로 DNA와 RNA를 방출하고 타액으로 들어오며, 돌연변이는 타액에서 매우 정확하게 탐지할 수 있습니다.
암 타액 검사 장치 시장 은 인간의 약물, 감염 또는 질병을 탐지하는 데 사용되는 검사 키트, 면봉, 카세트 및 장치로 구성됩니다. 여러 유형의 키트는 질병 탐지를 위해 다양한 유형의 분자 생물학 방법을 활용합니다. ELISA, PCR, 면역 검정 및 효소 검정은 타액 검사에 사용되는 분자 기술입니다.
아시아 태평양 암 침 검사 장치 시장 보고서는 시장 점유율, 새로운 개발 및 제품 파이프라인 분석, 국내 및 지역 시장 참여자의 영향, 새로운 수익 주머니, 시장 규정의 변화, 제품 승인, 전략적 의사 결정, 제품 출시, 지리적 확장 및 시장의 기술 혁신 측면에서의 분석 기회에 대한 세부 정보를 제공합니다. 분석 및 시장 시나리오를 이해하려면 분석가 브리핑을 위해 저희에게 연락하세요. 저희 팀은 원하는 목표를 달성하기 위한 수익 영향 솔루션을 만드는 데 도움을 드릴 것입니다.
Asia-Pacific Cancer Spit Test Device Market Scope and Market Size
Asia-Pacific cancer spit test device market is segmented on the basis of product type, site of collection, application, age group, method of collection, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of product type, the Asia-Pacific cancer spit test devices market is segmented into saliva collection kits, fluid specific devices, oral swab, bar-code labels, saliva cryostorage box, and others. In 2021, saliva collection kits segment is expected to dominate the market due to rising prevalence of cancer and growing geriatric population in the region.
- On the basis of site of collection, the Asia-Pacific cancer spit test devices market is segmented into sub-mandibular/sub-lingual gland, parotid gland, and minor salivary gland. In 2021, sub-mandibular/sub-lingual gland segment is expected to dominate the market owing to its non-invasive method and ease in collection.
- On the basis of application, the Asia-Pacific cancer spit test devices market is segmented into liver-lung cancer, breast cancer, colon and rectal cancer, prostate cancer, pancreatic cancer, oral cancer, thyroid cancer, endometrial cancer, kidney cancer, leukemia, melanoma, non-hodgkin lymphoma, and others. In 2021, liver-lung cancer segment is expected to dominate the market owing to rising environmental pollution and growing substance abuse among people.
- On the basis of age group, the Asia-Pacific cancer spit test devices market is segmented into adult and pediatrics. In 2021, adult segment is expected to dominate the market owing to rising prevalence of different types of cancers among elderly population.
- On the basis of method of collection, the Asia-Pacific cancer spit test devices market is segmented into passive drool, oral swab, and others. In 2021, passive drool segment is expected to dominate the market as it could be easily self-collected.
- On the basis of end user, the Asia-Pacific cancer spit test devices market is segmented into hospitals, diagnostic laboratories, oncology specialty clinics, cancer research institutes, and others. In 2021, hospitals segment is expected to dominate the market because of rising number of cancer cases and growing awareness among people regarding the disease.
- On the basis of distribution channel, the Asia-Pacific cancer spit test devices market is segmented into direct tender, retail sales, and others. In 2021, direct sales segment is expected to dominate the market owing to broad range of products availability and growing pool of cancer patients in the region.
Asia-Pacific Cancer Spit Test Devices Market Country Level Analysis
The Asia-Pacific cancer spit test devices market is analyzed and market size information is provided based on product type, site of collection, application, age group, method of collection, end user, and distribution channel.
Countries covered in the Asia-Pacific cancer spit test device market report are China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, and Rest of Asia-Pacific, The Asia-Pacific region is expected to grow with the most promising growth rate in the forecast period of 2021 to 2028 owing to rising prevalence of cancer cases in the region. China is dominating the Asia-Pacific market due to rising disposable income in the country.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Rising Healthcare Expenditure and High Prevalence of Cancer are Creating New Opportunities for Players in the Asia-Pacific Cancer Spit Test Devices Market
Saliva collection kits segment is dominating in China, which is leading in the Asia-Pacific region owing to growing geriatric population.
Asia-Pacific cancer spit test devices market also provides you with detailed market analysis for every country growth in particular industry with the Asia-Pacific cancer spit test device market sales, impact of advancement in the Asia-Pacific cancer spit test device market and changes in regulatory scenarios with their support for the Asia-Pacific cancer spit test devices market. The data is available for historic period 2010 to 2018.
Competitive Landscape and Asia-Pacific Cancer Spit Test Device Market Share Analysis
Asia-Pacific cancer spit test device market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, and technology lifeline curve. The above data points provided is only related to the companies’ focus related to Asia-Pacific cancer spit test devices market.
보고서에서 다루는 주요 기업으로는 DNA Genotek, Salimetrics, LLC, PeriRx, Color Health, Inc., SARSTEDT AG. Co. KG, Miraclean Technology Co.,Ltd., Agilent Technologies, Inc., Illumina, Inc., QIAGEN, Thermo Fisher Scientific Inc., Abbott, BD, Biocartis, bioMérieux SA, Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd, Oasis Diagnostics Corporation, Canvax(dobuss의 자회사) 등이 있습니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁사에 대한 경쟁 분석을 별도로 제공합니다.
또한 전 세계 여러 회사에서 다양한 제품 출시와 계약을 체결하면서 아시아 태평양 지역 암 침 검사 장비 시장이 더욱 가속화되고 있습니다.
예를 들어,
- 2021년 1월, DNA Genotek은 미국 식품의약국(FDA)이 OrageneDx 제품군에 대한 일반 사용 510(k) 허가를 내렸다고 발표했습니다. 이 FDA 승인은 시장에서 회사의 신뢰성을 높이고 이 제품에 대한 수요를 증가시켰습니다.
- 2021년 2월, Thermo Fisher Scientific은 6개의 CMO 리더십 상을 수상했습니다. 역량, 호환성, 전문성, 품질, 신뢰성, 서비스를 포함한 6개 부문에서 수상했습니다. Thermo Fisher가 6개 부문에서 수상한 것은 이번이 두 번째 연속이며, 회사가 CMO 리더십 상을 수상한 것은 전체적으로 여덟 번째입니다. 이를 통해 회사의 신뢰성이 높아지고 수익 창출에 도움이 되었습니다.
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 REGULATORY FRAMEWORKS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISE IN CANCER BURDEN WORLDWIDE
6.1.2 INCREASE IN INITIATIVES BY GOVERNMENT AND OTHER HEALTHCARE ORGANIZATIONS
6.1.3 RISE IN GERIATRIC POPULATION
6.1.4 RISE IN PRODUCT APPROVALS AND LAUNCHES FOR CANCER
6.1.5 RISE IN EXPENDITURE ON HEALTHCARE
6.2 RESTRAINTS
6.2.1 INCREASE PREVALENCE OF COVID-19
6.2.2 LACK OF EARLY DETECTION
6.3 OPPORTUNITIES
6.3.1 RECOMMENDATIONS FOR CANCER SCREENING
6.3.2 RISE IN DEMAND OF POINT-OF-CARE TESTING
6.3.3 RISE IN R&D ACTIVITIES
6.4 CHALLENGES
6.4.1 STRINGENT REGULATION POLICY
6.4.2 RISING COMPETITION AMONG MARKET PLAYERS
7 IMPACT OF COVID-19 THE ON ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET
7.1 IMPACT ON SUPPLY CHAIN
7.2 IMPACT ON DEMAND
7.3 STRATEGIC DECISIONS FOR MANUFACTURERS
7.4 CONCLUSION
8 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET, BY PRODUCT TYPE
8.1 OVERVIEW
8.2 SALIVA COLLECTION KIT
8.2.1 DNA EXTRACT
8.2.2 RNA EXTRACT
8.3 FLUID SPECIFIC DEVICES
8.4 ORAL SWAB
8.5 BAR-CODE LABELS
8.6 SALIVA CRYOSTORAGE BOX
8.7 OTHERS
9 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET, BY SITE OF COLLECTION
9.1 OVERVIEW
9.2 SUB-MANDIBULAR/SUB-LINGUAL GLAND
9.3 PAROTID GLAND
9.4 MINOR SALIVARY GLAND
10 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET, BY APPLICATION
10.1 OVERVIEW
10.2 LIVER-LUNG CANCER
10.3 BREAST CANCER
10.4 COLON AND RECTAL CANCER
10.5 PROSTATE CANCER
10.6 PANCREATIC CANCER
10.7 ORAL CANCER
10.8 THYROID CANCER
10.9 ENDOMETRIAL CANCER
10.1 KIDNEY CANCER
10.11 LEUKEMIA
10.12 MELANOMA
10.13 NON-HODGKIN LYMPHOMA
10.14 OTHERS
11 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET, BY AGE GROUP
11.1 OVERVIEW
11.2 ADULT
11.3 PEDIATRICS
12 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET, BY METHOD OF COLLECTION
12.1 OVERVIEW
12.2 PASSIVE DROOL
12.3 ORAL SWAB
12.4 OTHERS
13 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET, BY END USER
13.1 OVERVIEW
13.2 HOSPITALS
13.3 DIAGNOSTIC LABORATORIES
13.4 ONCOLOGY SPECIALITY CLINICS
13.5 CANCER RESEARCH INSTITUTES
13.6 OTHERS
14 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET, BY DISTRIBUTION CHANNEL
14.1 OVERVIEW
14.2 DIRECT TENDER
14.3 RETAIL SALES
14.4 OTHERS
15 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET, BY REGION
15.1 ASIA-PACIFIC
15.1.1 CHINA
15.1.2 INDIA
15.1.3 SOUTH KOREA
15.1.4 AUSTRALIA
15.1.5 JAPAN
15.1.6 SINGAPORE
15.1.7 THAILAND
15.1.8 MALAYSIA
15.1.9 INDONESIA
15.1.10 PHILIPPINES
15.1.11 REST OF ASIA-PACIFIC
16 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET: COMPANY LANDSCAPE
16.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
17 SWOT ANALYSIS
18 COMPANY PROFILE
18.1 BIOCARTIS
18.1.1 COMPANY SNAPSHOT
18.1.2 REVENUE ANALYSIS
18.1.3 COMPANY SHARE ANALYSIS
18.1.4 PRODUCT PORTFOLIO
18.1.5 RECENT DEVELOPMENTS
18.2 BD
18.2.1 COMPANY SNAPSHOT
18.2.2 COMPANY SHARE ANALYSIS
18.2.3 PRODUCT PORTFOLIO
18.2.4 RECENT DEVELOPMENT
18.3 ABBOTT
18.3.1 COMPANY SNAPSHOT
18.3.2 REVENUE ANALYSIS
18.3.3 COMPANY SHARE ANALYSIS
18.3.4 PRODUCT PORTFOLIO
18.3.5 RECENT DEVELOPMENT
18.4 F. HOFFMANN-LA ROCHE LTD
18.4.1 COMPANY SNAPSHOT
18.4.2 REVENUE ANALYSIS
18.4.3 COMPANY SHARE ANALYSIS
18.4.4 PRODUCT PORTFOLIO
18.4.5 RECENT DEVELOPMENT
18.5 QIAGEN
18.5.1 COMPANY SNAPSHOT
18.5.2 REVENUE ANALYSIS
18.5.3 COMPANY SHARE ANALYSIS
18.5.4 PRODUCT PORTFOLIO
18.5.5 RECENT DEVELOPMENTS
18.6 AGILENT TECHNOLOGIES, INC.
18.6.1 COMPANY SNAPSHOT
18.6.2 REVENUE ANALYSIS
18.6.3 PRODUCT PORTFOLIO
18.6.4 RECENT DEVELOPMENTS
18.7 BIOMÉRIEUX SA
18.7.1 COMPANY SNAPSHOT
18.7.2 REVENUE ANALYSIS
18.7.3 PRODUCT PORTFOLIO
18.7.4 RECENT DEVELOPMENT
18.8 CANVAX
18.8.1 COMPANY SNAPSHOT
18.8.2 PRODUCT PORTFOLIO
18.8.3 RECENT DEVELOPMENT
18.9 COLOR HEALTH, INC.
18.9.1 1.6.1 COMPANY SNAPSHOT
18.9.2 1.6.2 PRODUCT PORTFOLIO
18.9.3 RECENT DEVELOPMENT
18.1 DNA GENOTEK
18.10.1 COMPANY SNAPSHOT
18.10.2 REVENUE ANALYSIS
18.10.3 PRODUCT PORTFOLIO
18.10.4 RECENT DEVELOPMENT
18.11 ILLUMINA, INC.
18.11.1 COMPANY SNAPSHOT
18.11.2 REVENUE ANALYSIS
18.11.3 PRODUCT PORTFOLIO
18.11.4 RECENT DEVELOPMENTS
18.12 MIRACLEAN TECHNOLOGY CO.,LTD.
18.12.1 COMPANY SNAPSHOT
18.12.2 PRODUCT PORTFOLIO
18.12.3 RECENT DEVELOPMENT
18.13 OASIS DIAGNOSTICS CORPORATION
18.13.1 COMPANY SNAPSHOT
18.13.2 PRODUCT PORTFOLIO
18.13.3 RECENT DEVELOPMENT
18.14 PERIRX
18.14.1 COMPANY SNAPSHOT
18.14.2.2 PRODUCT PORTFOLIO
18.14.3 RECENT DEVELOPMENT
18.15 SALIMETRICS, LLC
18.15.1 COMPANY SNAPSHOT
18.15.2 PRODUCT PORTFOLIO
18.15.3 RECENT DEVELOPMENT
18.16 SARSTEDT AG & CO. KG
18.16.1 COMPANY SNAPSHOT
18.16.2 PRODUCT PORTFOLIO
18.16.3 RECENT DEVELOPMENT
18.17 SIEMENS HEALTHCARE S.A.E. (A SUBSIDIARY OF SIEMENS HEALTHINEERS AG)
18.17.1 COMPANY SNAPSHOT
18.17.2 REVENUE ANALYSIS
18.17.3 PRODUCT PORTFOLIO
18.17.4 RECENT DEVELOPMENTS
18.18 THERMO FISHER SCIENTIFIC INC.
18.18.1 COMPANY SNAPSHOT
18.18.2 REVENUE ANALYSIS
18.18.3 PRODUCT PORTFOLIO
18.18.4 RECENT DEVELOPMENT
19 QUESTIONNAIRE
20 RELATED REPORTS
표 목록
LIST OF TABLES
TABLE 1 NEW CANCER CASES, AGES 85+, IN THE U.S.
TABLE 2 DEATH CAUSES DUE TO CANCER, AGES 85+, IN THE U.S.
TABLE 3 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 4 ASIA-PACIFIC SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 5 ASIA-PACIFIC SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 6 ASIA-PACIFIC FLUID SPECIFIC DEVICES IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 ASIA-PACIFIC ORAL SWAB IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 8 ASIA-PACIFIC BAR-CODE LABELS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 9 ASIA-PACIFIC SALIVA CRYOSTORAGE BOX IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 10 ASIA-PACIFIC OTHERS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 11 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET, BY SITE OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 12 ASIA-PACIFIC SUB-MANDIBULAR/SUB-LINGUAL GLAND IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 ASIA-PACIFIC PAROTID GLAND IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 14 ASIA-PACIFIC MINOR SALIVARY GLAND IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 15 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 16 ASIA-PACIFIC LIVER-LUNG CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 ASIA-PACIFIC BREAST CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 ASIA-PACIFIC COLON AND RECTAL CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 19 ASIA-PACIFIC PROSTATE CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 ASIA-PACIFIC PANCREATIC CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 21 ASIA-PACIFIC ORAL CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 ASIA-PACIFIC THYROID CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 ASIA-PACIFIC ENDOMETRIAL CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 ASIA-PACIFIC KIDNEY CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 25 ASIA-PACIFIC LEUKEMIA IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 ASIA-PACIFIC MELANOMA IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 ASIA-PACIFIC NON-HODGKIN LYMPHOMA IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 ASIA-PACIFIC OTHERS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
TABLE 30 ASIA-PACIFIC ADULT IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 31 ASIA-PACIFIC PEDIATRICS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 32 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET, BY METHOD OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 33 ASIA-PACIFIC PASSIVE DROOL IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 34 ASIA-PACIFIC ORAL SWAB IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 35 ASIA-PACIFIC OTHERS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 36 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 37 ASIA-PACIFIC HOSPITALS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 38 ASIA-PACIFIC DIAGNOSTIC LABORATORIES IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 39 ASIA-PACIFIC ONCOLOGY SPECIALITY CLINICS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 40 ASIA-PACIFIC CANCER RESEARCH INSTITUTES IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 41 ASIA-PACIFIC OTHERS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 42 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 43 ASIA-PACIFIC DIRECT TENDER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 44 ASIA-PACIFIC RETAIL SALES IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 45 ASIA-PACIFIC OTHERS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 46 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 47 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 48 ASIA-PACIFIC SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 49 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET, BY SITE OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 50 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 51 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
TABLE 52 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET, BY METHOD OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 53 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 54 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 55 CHINA CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 56 CHINA SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 57 CHINA CANCER SPIT TEST DEVICES MARKET, BY SITE OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 58 CHINA CANCER SPIT TEST DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 59 CHINA CANCER SPIT TEST DEVICES MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
TABLE 60 CHINA CANCER SPIT TEST DEVICES MARKET, BY METHOD OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 61 CHINA CANCER SPIT TEST DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 62 CHINA CANCER SPIT TEST DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 63 INDIA CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 64 INDIA SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 65 INDIA CANCER SPIT TEST DEVICES MARKET, BY SITE OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 66 INDIA CANCER SPIT TEST DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 67 INDIA CANCER SPIT TEST DEVICES MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
TABLE 68 INDIA CANCER SPIT TEST DEVICES MARKET, BY METHOD OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 69 INDIA CANCER SPIT TEST DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 70 INDIA CANCER SPIT TEST DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 71 SOUTH KOREA CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 72 SOUTH KOREA SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 73 SOUTH KOREA CANCER SPIT TEST DEVICES MARKET, BY SITE OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 74 SOUTH KOREA CANCER SPIT TEST DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 75 SOUTH KOREA CANCER SPIT TEST DEVICES MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
TABLE 76 SOUTH KOREA CANCER SPIT TEST DEVICES MARKET, BY METHOD OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 77 SOUTH KOREA CANCER SPIT TEST DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 78 SOUTH KOREA CANCER SPIT TEST DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 79 AUSTRALIA CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 80 AUSTRALIA SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 81 AUSTRALIA CANCER SPIT TEST DEVICES MARKET, BY SITE OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 82 AUSTRALIA CANCER SPIT TEST DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 83 AUSTRALIA CANCER SPIT TEST DEVICES MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
TABLE 84 AUSTRALIA CANCER SPIT TEST DEVICES MARKET, BY METHOD OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 85 AUSTRALIA CANCER SPIT TEST DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 86 AUSTRALIA CANCER SPIT TEST DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 87 JAPAN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 88 JAPAN SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 89 JAPAN CANCER SPIT TEST DEVICES MARKET, BY SITE OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 90 JAPAN CANCER SPIT TEST DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 91 JAPAN CANCER SPIT TEST DEVICES MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
TABLE 92 JAPAN CANCER SPIT TEST DEVICES MARKET, BY METHOD OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 93 JAPAN CANCER SPIT TEST DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 94 JAPAN CANCER SPIT TEST DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 95 SINGAPORE CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 96 SINGAPORE SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 97 SINGAPORE CANCER SPIT TEST DEVICES MARKET, BY SITE OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 98 SINGAPORE CANCER SPIT TEST DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 99 SINGAPORE CANCER SPIT TEST DEVICES MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
TABLE 100 SINGAPORE CANCER SPIT TEST DEVICES MARKET, BY METHOD OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 101 SINGAPORE CANCER SPIT TEST DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 102 SINGAPORE CANCER SPIT TEST DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 103 THAILAND CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 104 THAILAND SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 105 THAILAND CANCER SPIT TEST DEVICES MARKET, BY SITE OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 106 THAILAND CANCER SPIT TEST DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 107 THAILAND CANCER SPIT TEST DEVICES MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
TABLE 108 THAILAND CANCER SPIT TEST DEVICES MARKET, BY METHOD OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 109 THAILAND CANCER SPIT TEST DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 110 THAILAND CANCER SPIT TEST DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 111 MALAYSIA CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 112 MALAYSIA SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 113 MALAYSIA CANCER SPIT TEST DEVICES MARKET, BY SITE OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 114 MALAYSIA CANCER SPIT TEST DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 115 MALAYSIA CANCER SPIT TEST DEVICES MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
TABLE 116 MALAYSIA CANCER SPIT TEST DEVICES MARKET, BY METHOD OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 117 MALAYSIA CANCER SPIT TEST DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 118 MALAYSIA CANCER SPIT TEST DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 119 INDONESIA CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 120 INDONESIA SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 121 INDONESIA CANCER SPIT TEST DEVICES MARKET, BY SITE OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 122 INDONESIA CANCER SPIT TEST DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 123 INDONESIA CANCER SPIT TEST DEVICES MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
TABLE 124 INDONESIA CANCER SPIT TEST DEVICES MARKET, BY METHOD OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 125 INDONESIA CANCER SPIT TEST DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 126 INDONESIA CANCER SPIT TEST DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 127 PHILIPPINES CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 128 PHILIPPINES SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 129 PHILIPPINES CANCER SPIT TEST DEVICES MARKET, BY SITE OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 130 PHILIPPINES CANCER SPIT TEST DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 131 PHILIPPINES CANCER SPIT TEST DEVICES MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
TABLE 132 PHILIPPINES CANCER SPIT TEST DEVICES MARKET, BY METHOD OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 133 PHILIPPINES CANCER SPIT TEST DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 134 PHILIPPINES CANCER SPIT TEST DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 135 REST OF ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
그림 목록
LIST OF FIGURES
FIGURE 1 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET : SEGMENTATION
FIGURE 2 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET : DATA TRIANGULATION
FIGURE 3 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET : DROC ANALYSIS
FIGURE 4 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET: ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET : COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET : INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET : DBMR MARKET POSITION GRID
FIGURE 8 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET : MARKET APPLICATION COVERAGE GRID
FIGURE 9 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET : VENDOR SHARE ANALYSIS
FIGURE 10 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET : SEGMENTATION
FIGURE 11 THE INCREASING PREVALENCE OF CHRONIC DISEASES AND RISING HEALTHCARE EXPENDITURE ARE EXPECTED TO DRIVE THE ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 SALVIA COLLECTION KIT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET IN 2021 & 2028
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET
FIGURE 14 ESTIMATED NUMBER OF NEW CASES IN 2018, WORLDWIDE, BOTH SEXES, ALL AGES
FIGURE 15 ESTIMATED AGE-STANDARDIZED INCIDENCE RATES (WORLD) IN 2018, WORLDWIDE, BOTH SEXES, ALL AGES
FIGURE 16 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: BY PRODUCT TYPE, 2020
FIGURE 17 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: BY PRODUCT TYPE, 2021-2028 (USD MILLION)
FIGURE 18 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: BY PRODUCT TYPE, CAGR (2021-2028)
FIGURE 19 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 20 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: BY SITE OF COLLECTION, 2020
FIGURE 21 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: BY SITE OF COLLECTION, 2021-2028 (USD MILLION)
FIGURE 22 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: BY SITE OF COLLECTION, CAGR (2021-2028)
FIGURE 23 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: BY SITE OF COLLECTION, LIFELINE CURVE
FIGURE 24 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: BY APPLICATION, 2020
FIGURE 25 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: BY APPLICATION, 2021-2028 (USD MILLION)
FIGURE 26 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: BY APPLICATION, CAGR (2021-2028)
FIGURE 27 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 28 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: BY AGE GROUP, 2020
FIGURE 29 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: BY AGE GROUP, 2021-2028 (USD MILLION)
FIGURE 30 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: BY AGE GROUP, CAGR (2021-2028)
FIGURE 31 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: BY AGE GROUP, LIFELINE CURVE
FIGURE 32 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: BY METHOD OF COLLECTION, 2020
FIGURE 33 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: BY METHOD OF COLLECTION, 2021-2028 (USD MILLION)
FIGURE 34 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: BY METHOD OF COLLECTION, CAGR (2021-2028)
FIGURE 35 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: BY METHOD OF COLLECTION, LIFELINE CURVE
FIGURE 36 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: END USER, 2020
FIGURE 37 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: END USER, 2021-2028 (USD MILLION)
FIGURE 38 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: END USER, CAGR (2021-2028)
FIGURE 39 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: END USER, LIFELINE CURVE
FIGURE 40 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 41 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
FIGURE 42 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 43 ASIA-PACIFIC CANCER SPIT TEST DEVICE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 44 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET : SNAPSHOT (2020)
FIGURE 45 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET : BY COUNTRY (2020)
FIGURE 46 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET : BY COUNTRY (2021 & 2028)
FIGURE 47 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET : BY COUNTRY (2020 & 2028)
FIGURE 48 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET : BY PRODUCT TYPE (2021-2028)
FIGURE 49 ASIA-PACIFIC CANCER SPIT TEST DEVICES MARKET: COMPANY SHARE 2020 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.